Category: Health

Phase 3 Registry Listing Describes CBL-514 Study for Abdominal Subcutaneous Fat

A ClinicalTrials.gov listing describes a Phase 3 trial of CBL-514 injection for abdominal subcutaneous fat, using a randomized, double-blinded, placebo-controlled design.

Read More

Follow Us

Advertisements